Double-Blind Naltrexone in Compulsive Sexual Behavior
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in
compulsive sexual behavior. Twenty subjects with DSM-IV compulsive sexual behavior will
receive 8 weeks of naltrexone or placebo. The hypothesis to be tested is that naltrexone will
be effective in reducing the urges to act out sexually in patients with compulsive sexual
behavior. The proposed study will provide needed data on the treatment of a disabling
disorder that currently lacks a clearly effective treatment.
Phase:
Phase 2
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute